GREY:IPHAF - Post by User
Comment by
culateron Jul 02, 2008 1:04pm
441 Views
Post# 15250171
RE: RBC drops target to $3 from $4
RE: RBC drops target to $3 from $4RBC gal is just covering her butt so that no matter which way the stock goes she can say I told you so (similar to the posts we get from TeeVee). She knows less about this stock and this drug than the people who read and post on this board. If you read and post on this board you probably have an invested interest in this company. We all know that share price hinges on a Roche opt in. Our due diligence and some crystal ball gazing say there is no reason for Roche not to excersize their option. If they do it provides confidence to the investment community and share price should reflect this no matter what anonymous(e) (or mouses) do. As long as someone out there feels the stock is worth only .73 cents and is willing to take it, that's what the share price will be. If everyone decides the stock is worth $5.00/share at some point then you only need about 100 shares to trade hands to place the price there. So as RBC has lowered their price to $3.00, I have raised my price to $5.00, with just about as much knowledge and pedictability as RBC. It was there eight years ago with no positive test results and much less opportunity.
Have a great summer.
culater